141 related articles for article (PubMed ID: 34493460)
1. Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis.
Huebner H; Lubrich H; Blum S; Antoniadis S; Lermann J; Ekici A; Fasching PA; Beckmann MW; Ruebner M; Burghaus S
Reprod Biomed Online; 2021 Nov; 43(5):788-798. PubMed ID: 34493460
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows.
Lehle S; Emons J; Hack CC; Heindl F; Hein A; Preuß C; Seitz K; Zahn AL; Beckmann MW; Fasching PA; Ruebner M; Huebner H
Sci Rep; 2023 Jan; 13(1):373. PubMed ID: 36611077
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of commercial kits for purification of circulating free DNA.
Diefenbach RJ; Lee JH; Kefford RF; Rizos H
Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients.
Leest PV; Boonstra PA; Elst AT; Kempen LCV; Tibbesma M; Koopmans J; Miedema A; Tamminga M; Groen HJM; Reyners AKL; Schuuring E
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414097
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
Lampignano R; Neumann MHD; Weber S; Kloten V; Herdean A; Voss T; Groelz D; Babayan A; Tibbesma M; Schlumpberger M; Chemi F; Rothwell DG; Wikman H; Galizzi JP; Riise Bergheim I; Russnes H; Mussolin B; Bonin S; Voigt C; Musa H; Pinzani P; Lianidou E; Brady G; Speicher MR; Pantel K; Betsou F; Schuuring E; Kubista M; Ammerlaan W; Sprenger-Haussels M; Schlange T; Heitzer E
Clin Chem; 2020 Jan; 66(1):149-160. PubMed ID: 31628139
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Evaluation of the Factors Affecting Plasma Circulating Cell-Free DNA Levels and Their Application in Diagnosing Nonsmall Cell Lung Cancer.
Chen Z; Zhang S; Li C; Xu C; Zhao J; Miao L
Genet Test Mol Biomarkers; 2019 Apr; 23(4):270-276. PubMed ID: 30986099
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma.
Mauger F; Dulary C; Daviaud C; Deleuze JF; Tost J
Anal Bioanal Chem; 2015 Sep; 407(22):6873-8. PubMed ID: 26123439
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
9. Performance comparison of commercial kits for isolating and detecting circulating tumor DNA.
Wang M; Huang X; Li X; Guo Q; Xu W; Zhao M; Wang X; Wang L; Lou J
Scand J Clin Lab Invest; 2021 Jul; 81(4):276-281. PubMed ID: 33999736
[TBL] [Abstract][Full Text] [Related]
10. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.
Terp SK; Pedersen IS; Stoico MP
J Mol Diagn; 2024 Apr; 26(4):310-319. PubMed ID: 38336350
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson's Disease Patients.
Wojtkowska M; Karczewska N; Pacewicz K; Pacak A; Kopeć P; Florczak-Wyspiańska J; Popławska-Domaszewicz K; Małkiewicz T; Sokół B
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474065
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.
Jain M; Balatsky AV; Revina DB; Samokhodskaya LM
Mol Cell Probes; 2019 Feb; 43():13-19. PubMed ID: 30584912
[TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free DNA in patients with alveolar echinococcosis.
Baraquin A; Hervouet E; Richou C; Flori P; Peixoto P; Azizi A; Delabrousse E; Blagosklonov O; Umhang G; Bresson-Hadni S; Valot B; Grenouillet F;
Mol Biochem Parasitol; 2018 Jun; 222():14-20. PubMed ID: 29679605
[TBL] [Abstract][Full Text] [Related]
14. An automated, high-throughput methodology optimized for quantitative cell-free mitochondrial and nuclear DNA isolation from plasma.
Ware SA; Desai N; Lopez M; Leach D; Zhang Y; Giordano L; Nouraie M; Picard M; Kaufman BA
J Biol Chem; 2020 Nov; 295(46):15677-15691. PubMed ID: 32900851
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
[TBL] [Abstract][Full Text] [Related]
16. Accurate Measurement of Cellular and Cell-Free Circulating Mitochondrial DNA Content from Human Blood Samples Using Real-Time Quantitative PCR.
Rosa H; Malik AN
Methods Mol Biol; 2021; 2277():247-268. PubMed ID: 34080155
[TBL] [Abstract][Full Text] [Related]
17. Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care.
El Messaoudi S; Mouliere F; Du Manoir S; Bascoul-Mollevi C; Gillet B; Nouaille M; Fiess C; Crapez E; Bibeau F; Theillet C; Mazard T; Pezet D; Mathonnet M; Ychou M; Thierry AR
Clin Cancer Res; 2016 Jun; 22(12):3067-77. PubMed ID: 26847055
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of circulating cell free DNA in plasma as a biomarker of different thyroid diseases.
Caglar O; Cilgin B; Eroglu M; Cayir A
Braz J Otorhinolaryngol; 2020; 86(3):321-326. PubMed ID: 30826312
[TBL] [Abstract][Full Text] [Related]
19. Circulating cell-free-DNA concentration is a good biomarker for diagnosis of colorectal cancer in Mexican patients.
Saucedo-Sariñana AM; Lugo-Escalante CR; Barros-Núñez P; Marín-Contreras ME; Pineda-Razo TD; Mariscal-Ramírez I; Gallegos-Arreola MP; Rosales-Reynoso MA
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):1-8. PubMed ID: 36227685
[TBL] [Abstract][Full Text] [Related]
20. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis.
Hashimoto T; Yoshida K; Hashimoto N; Nakai A; Kaneshiro K; Suzuki K; Kawasaki Y; Shibanuma N; Hashiramoto A
Int J Rheum Dis; 2017 Jun; 20(6):722-730. PubMed ID: 27943573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
